With winter setting in around much of the country, many people are also gearing up for cough and cold season. But the Food ...

Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

The drug is the only immuno-oncology drug approved by various regulatory authorities around the world for the treatment of ...

A troubling sex trend is making its way across college campuses nationwide, and doctors are concerned. Healthy college men ...

Dr Reddy’s Laboratories launches Toripalimab, the first immuno-oncology drug for nasopharyngeal carcinoma, in India.

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's gene therapy for the rare ...

Geoffrey Pointing says its hard to describe the distress of an asthma or COPD flare-up. "Honestly, when you're having a flare ...

Get Anti-cancer drug Toripalimab News on Telangana Today, Anti-cancer drug Toripalimab latest news, Anti-cancer drug Toripalimab news, | Telangana Today ...

Applied Therapeutics faces challenges after FDA rejection, but future opportunities exist. Learn why APLT stock could recover ...

Dr Reddy's already signed a license and commercialisation deal for Toripalimab with Shanghai Junshi Biosciences Co. Ltd in ...

Novartis wins EC approval for Kisqali in a broad population of patients with HR+/HER2- early breast cancer at high risk of recurrence.

Xcopri is being heralded by the Canadian Epilepsy Alliance and the Canadian League Against Epilepsy as a promising treatment for partial onset seizures in adults.